7 Real Ways to Get GLP-1 Medications Without Insurance in 2026

The market for GLP-1 access shifted fast this year. Several major telehealth brands dropped compounded options after a March 2026 settlement between Novo Nordisk and some of the biggest names in the space, pushing those companies toward branded drugs that cost two to four times more. That left a narrower field of genuinely affordable, cash-pay options, and it made the differences between providers matter a lot more than they used to.

1. FormBlends

FormBlends took a different path than the brands that retreated. While others moved toward branded Wegovy and Zepbound at $299 to $399 a month, FormBlends kept compounded semaglutide at $299 per vial and compounded tirzepatide at $349, with the price sitting right on the product page before anyone fills out a form. No membership stacked underneath. No surprise billing after checkout.

The process is straightforward. A short intake leads to physician review, and if approved, medication ships through a 503A compounding pharmacy partner that operates under cGMP standards with FDA inspection. Cold-chain handling is included. Forty-seven states are covered.

What actually sets it apart is testable quality data. Each batch goes through three lab checks: HPLC for purity, mass spectrometry for molecular identity, and bacterial contamination screening. The purity results are published by product, not hidden in a generic certificate. Semaglutide comes in at 99.1%, tirzepatide at 99.3%. Most telehealth-only brands publish nothing equivalent.

There is also something no pure weight-loss platform offers: the same physician-supervised prescription model extends across a full catalog of compounded peptides, BPC-157, NAD+, growth hormone secretagogues, and others. That is genuinely unusual. Most peptide vendors are research-only, no prescriber in sight. Most GLP-1 platforms stop at GLP-1s. FormBlends connects both under one clinical roof.

Compounded medications are not FDA-approved. That applies here and everywhere else on this list.

Best for: Cash-pay patients who want GLP-1 access plus the option to add other compounded peptides later, all under one prescriber, without paying a monthly platform fee on top of the medication price.

2. Mochi Health

Mochi charges roughly $99 a month for compounded semaglutide and $199 for compounded tirzepatide, with three- and twelve-month commitments bringing the price down further. What earns it the second spot is the clinical model. Board-certified obesity medicine specialists handle prescribing, not general practitioners rotating through a telehealth queue. That matters for patients who have tried and failed with generic programs. Monitoring is more active than most competitors at this price point.

Pro: Actual obesity-medicine expertise baked into the model.

Con: Tirzepatide at $199 is cheaper than FormBlends’ $349, but purity testing details are not published at the same product-level specificity.

3. Henry Meds

Henry Meds focuses on speed and simplicity. First-month pricing typically lands between $179 and $249, and shipments frequently go out within 24 to 72 hours of approval. The intake is light. That speed appeals to people who want to start quickly and do not need extensive hand-holding.

Pro: Genuinely fast turnaround from approval to delivery.

Con: Ongoing clinical monitoring is lighter than what Mochi or FormBlends provides. Not the right fit for patients with complex metabolic histories.

4. MEDVi

MEDVi offers compounded GLP-1 at around $179 for the first month with no contracts and no recurring membership fee. Physician review is included, and the company advertises around-the-clock support access. Structurally, it is similar to Henry Meds but positions itself as slightly more clinician-forward.

Pro: No-contract cash pricing with physician oversight from day one.

Con: Smaller brand footprint means less third-party coverage and fewer patient reviews to evaluate long-term experience.

5. Hims and Hers

Hims and Hers exited compounded GLP-1s after the March 2026 Novo Nordisk settlement. New patients are now routed to branded drugs. Injectable Wegovy runs about $299 a month, oral Wegovy about $249, and Zepbound about $399. For patients with commercial insurance who can layer in a savings card, the out-of-pocket cost can drop to nearly nothing. That is the real use case here now.

Pro: Slick app experience, fast onboarding, and branded drugs that carry full FDA approval.

Con: Without insurance or a working savings card, these prices are the highest on this list for ongoing monthly cost.

6. Ro Body

Ro’s membership model starts at roughly $39 for the first month, stepping up to around $149 month-to-month or as low as $74 monthly on an annual prepay. Medication is billed separately on top of that. Ro has a prior-authorization team that works with insurance, which is a real operational benefit for patients chasing branded drug coverage. The platform is polished and has been around long enough to have earned a real track record.

Pro: Prior-auth support is one of the better-executed features in the telehealth GLP-1 space.

Con: The membership-plus-medication billing structure makes true monthly cost harder to read upfront compared to flat per-vial pricing.

7. PlushCare

PlushCare operates as a broader telehealth platform with an app membership at roughly $19.99 a month. It prescribes FDA-approved branded drugs, including Ozempic, Wegovy, and Mounjaro, accepts insurance, and offers same-day appointments. Lab work and prescription fulfillment cost extra beyond the membership. For patients who already have insurance coverage and just need a quick prescriber visit to get started, it is a low-friction entry point.

Pro: Same-day appointments and insurance acceptance make it fast for people who already have coverage.

Con: Without insurance, the branded drugs prescribed here are expensive. This is not a cash-pay GLP-1 solution in any practical sense.

Getting GLP-1 medications without insurance in 2026 is genuinely possible, but the differences between platforms are real. Price transparency, clinical oversight, and what happens after month one vary widely. Nothing here substitutes for a conversation with a licensed clinician who knows your full medical history before you begin any GLP-1 or compounded medication program.